XML 50 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1

Revenue (Tables)

12 Months Ended

Dec. 29, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table summarizes Total revenues by business unit:

			Fiscal Year Ended
(In millions)			2024						2023						2022
Labs			$	1,426.7					$	1,425.4					$	820.2
Immunohematology (1)			522.6						512.4						296.8
Donor Screening (1)			115.5						136.1						97.0
Point of Care			694.1						892.2						1,955.3
Molecular Diagnostics			24.0						31.7						96.7
Total revenues			$	2,782.9					$	2,997.8					$	3,266.0

(1) For presentation purposes, as a result of the wind-down of the U.S. donor screening portfolio, the previously reported Transfusion Medicine business unit is shown in its two product categories: Immunohematology and Donor Screening. Prior periods have been revised to align with the current period presentation.

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration